Quantinno Capital Management LP Purchases New Shares in HealthEquity, Inc. (NASDAQ:HQY)

Quantinno Capital Management LP bought a new stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 3,174 shares of the company's stock, valued at approximately $305,000.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in HQY. Barclays PLC increased its position in HealthEquity by 209.3% in the 3rd quarter. Barclays PLC now owns 166,492 shares of the company's stock valued at $13,628,000 after buying an additional 112,667 shares in the last quarter. UMB Bank n.a. increased its holdings in HealthEquity by 65.6% during the 4th quarter. UMB Bank n.a. now owns 414 shares of the company's stock worth $40,000 after purchasing an additional 164 shares in the last quarter. Ballentine Partners LLC bought a new stake in HealthEquity during the 4th quarter worth approximately $228,000. Atomi Financial Group Inc. increased its holdings in HealthEquity by 39.8% during the 4th quarter. Atomi Financial Group Inc. now owns 3,553 shares of the company's stock worth $341,000 after purchasing an additional 1,012 shares in the last quarter. Finally, Nisa Investment Advisors LLC increased its holdings in HealthEquity by 8.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 3,719 shares of the company's stock worth $357,000 after purchasing an additional 299 shares in the last quarter. 99.55% of the stock is owned by institutional investors.

HealthEquity Stock Up 0.3%

Shares of HealthEquity stock traded up $0.34 during midday trading on Wednesday, hitting $101.48. The company had a trading volume of 1,035,516 shares, compared to its average volume of 808,905. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The stock has a market capitalization of $8.78 billion, a P/E ratio of 93.10, a P/E/G ratio of 1.60 and a beta of 0.45. The company has a 50 day moving average of $88.65 and a 200 day moving average of $97.42. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on HQY. The Goldman Sachs Group decreased their price objective on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a report on Thursday, March 27th. Barrington Research reissued an "outperform" rating and set a $112.00 price objective on shares of HealthEquity in a report on Friday, April 11th. KeyCorp reduced their target price on HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. Royal Bank of Canada started coverage on HealthEquity in a report on Thursday, May 22nd. They issued an "outperform" rating and a $112.00 target price for the company. Finally, Wells Fargo & Company upped their target price on HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, HealthEquity has a consensus rating of "Buy" and a consensus price target of $112.33.

Insider Activity at HealthEquity

In related news, EVP Michael Henry Fiore sold 8,881 shares of the company's stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the transaction, the executive vice president now directly owns 56,655 shares of the company's stock, valued at approximately $4,433,820.30. This represents a 13.55% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Robert W. Selander sold 5,750 shares of the stock in a transaction on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total value of $446,487.50. Following the transaction, the director now directly owns 84,969 shares in the company, valued at $6,597,842.85. The trade was a 6.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.